Association between dopamine and somatostatin receptor expression and pharmacological response to somatostatin analogues in acromegaly.

about

Association between dopamine and somatostatin receptor expression and pharmacological response to somatostatin analogues in acromegaly.

Item

http://www.wikidata.org/entity/Q48366708

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Association between dopamine a ...... tatin analogues in acromegaly.

@en

Association between dopamine a ...... tatin analogues in acromegaly.

@nl

type

Item

label

Association between dopamine a ...... tatin analogues in acromegaly.

@en

Association between dopamine a ...... tatin analogues in acromegaly.

@nl

prefLabel

Association between dopamine a ...... tatin analogues in acromegaly.

@en

Association between dopamine a ...... tatin analogues in acromegaly.

@nl

P1476

Association between dopamine a ...... statin analogues in acromegaly

@en

P2093

Ainara Madrazo-Atutxa

http://www.w3.org/2001/XMLSchema#string

Alvaro Flores-Martinez

http://www.w3.org/2001/XMLSchema#string

Elena Dios

http://www.w3.org/2001/XMLSchema#string

Esther Rivero-Cortés

http://www.w3.org/2001/XMLSchema#string

Eva Venegas-Moreno

http://www.w3.org/2001/XMLSchema#string

Mari C Vazquez-Borrego

http://www.w3.org/2001/XMLSchema#string

Miguel A Japón

http://www.w3.org/2001/XMLSchema#string

Noelia Gros-Herguido

http://www.w3.org/2001/XMLSchema#string

P2860

Acromegaly pathogenesis and treatment

Place of preoperative treatment of acromegaly with somatostatin analog on surgical outcome: a systematic review and meta-analysis

Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity.

Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomas

Differential somatostatin receptor (SSTR) 1-5 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumors

In1-ghrelin splicing variant is overexpressed in pituitary adenomas and increases their aggressive features.

Dimerization of G protein-coupled receptors: new avenues for somatostatin receptor signalling, control and functioning.

Expression analysis of dopamine receptor subtypes in normal human pituitaries, nonfunctioning pituitary adenomas and somatotropinomas, and the association between dopamine and somatostatin receptors with clinical response to octreotide-LAR in acrome

Management of aggressive pituitary adenomas: current treatment strategies.

Atypical pituitary adenomas: incidence, clinical characteristics, and implications.

P304

1640-1649

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JCMM.13440

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29266696

http://www.w3.org/2001/XMLSchema#string

P932

5824369

http://www.w3.org/2001/XMLSchema#string